Schindler CW et al. |
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys. |
2016 |
Psychopharmacology (Berl.) |
pmid:26803499
|
Fernandez-Espejo E and Galan-Rodriguez B |
Sensorimotor gating in mice is disrupted after AM404, an anandamide reuptake and degradation inhibitor. |
2004 |
Psychopharmacology (Berl.) |
pmid:15088080
|
Cassano T et al. |
Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. |
2011 |
Psychopharmacology (Berl.) |
pmid:21042794
|
Panlilio LV et al. |
Anandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats. |
2009 |
Psychopharmacology (Berl.) |
pmid:19015836
|
Schacht JP et al. |
Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. |
2009 |
Psychopharmacology (Berl.) |
pmid:19002671
|
Heyman E et al. |
Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression. |
2012 |
Psychoneuroendocrinology |
pmid:22029953
|
Hill MN et al. |
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. |
2009 |
Psychoneuroendocrinology |
pmid:19394765
|
Gray JM et al. |
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function. |
2016 |
Psychoneuroendocrinology |
pmid:26821211
|
Fride E and Mechoulam R |
Developmental aspects of anandamide: ontogeny of response and prenatal exposure. |
1996 |
Psychoneuroendocrinology |
pmid:8774060
|
Kaufmann I et al. |
Anandamide and neutrophil function in patients with fibromyalgia. |
2008 |
Psychoneuroendocrinology |
pmid:18395993
|